These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 25445919)

  • 1. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer.
    Shan NL; Wahler J; Lee HJ; Bak MJ; Gupta SD; Maehr H; Suh N
    J Steroid Biochem Mol Biol; 2017 Oct; 173():122-129. PubMed ID: 27923595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma
    Shan NL; Minden A; Furmanski P; Bak MJ; Cai L; Wernyj R; Sargsyan D; Cheng D; Wu R; Kuo HD; Li SN; Fang M; Maehr H; Kong AN; Suh N
    Cancer Prev Res (Phila); 2020 Aug; 13(8):673-686. PubMed ID: 32467291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer.
    So JY; Lee HJ; Smolarek AK; Paul S; Wang CX; Maehr H; Uskokovic M; Zheng X; Conney AH; Cai L; Liu F; Suh N
    Mol Pharmacol; 2011 Mar; 79(3):360-7. PubMed ID: 21115634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.
    Kim SH; Sehrawat A; Singh SV
    Cancer Prev Res (Phila); 2013 Aug; 6(8):782-90. PubMed ID: 23661606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
    Chen D; Bhat-Nakshatri P; Goswami C; Badve S; Nakshatri H
    Cancer Res; 2013 Sep; 73(18):5821-33. PubMed ID: 23832666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.
    Wahler J; So JY; Kim YC; Liu F; Maehr H; Uskokovic M; Suh N
    Cancer Prev Res (Phila); 2014 Jun; 7(6):617-26. PubMed ID: 24691501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.
    Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y
    Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
    Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
    Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
    Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
    Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer stem cells in solid tumors by vitamin D.
    So JY; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():79-85. PubMed ID: 25460302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.
    So JY; Smolarek AK; Salerno DM; Maehr H; Uskokovic M; Liu F; Suh N
    PLoS One; 2013; 8(1):e54020. PubMed ID: 23326564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
    Das T; Nair RR; Green R; Padhee S; Howell M; Banerjee J; Mohapatra SS; Mohapatra S
    Anticancer Res; 2017 Apr; 37(4):1655-1663. PubMed ID: 28373426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.